Point72 (Difc) LTD Abb Vie Inc. Call Options Transaction History

Point72 (Difc) LTD

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $6.8 Million - $8.27 Million	-41,500 Reduced 79.2%	10,900 $2.15 Billion
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $6.72 Million - $7.84 Million	43,400 Added 482.22%	52,400 $8.99 Billion
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $1.44 Million - $1.64 Million	9,000 New	9,000 $1.64 Billion

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 (Difc) LTD with notifications on news.